Erythema multiforme after meningitis vaccine: Patient safety concerns with repeat immunization

Pharmacotherapy

Volumn 26, Issue 11, 2006, Pages 1658-1661

  Studdiford, James ^a,b   Oppenheim, Laura ^b   McCann, Edward ^b   Altshuler, Marc ^a,b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Erythema multiforme; Menactra; Meningitis vaccine; Stevens Johnson syndrome; Vaccination

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; DIPHTHERIA TOXOID; MENINGITIS VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE; STEROID;

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CASE REPORT; COLLEGE STUDENT; DRUG ERUPTION; DRUG SAFETY; ERYTHEMA MULTIFORME; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HUMAN; HYPERSENSITIVITY REACTION; IMMUNIZATION; MALE; MOUTH LESION; ORAL BLISTER; PATIENT SAFETY; PURPURA; RASH; RETREATMENT; SKIN EDEMA; SKIN MANIFESTATION; SKIN PRURITUS; STEVENS JOHNSON SYNDROME; URTICARIA; VACCINATION;

ADULT; DIPHENHYDRAMINE; DRUG ERUPTIONS; ERYTHEMA MULTIFORME; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNIZATION; MALE; MENINGOCOCCAL VACCINES; VACCINES, CONJUGATE;

EID: 33750717577     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.11.1658     Document Type: Article

References (15)

1. Immunization Action Coalition. Vaccine information for the public and health professionals. Available from http://www. vaccineinformation.org/menin/ qandavax.asp. Accessed August 18, 2006.
2. Stampien TM, Schwartz RA. Erythema multiforme. Am Fam Physician 1992;46:1171-6.
3. Habif TP, Campbell JL, Chapman MS, Dinulos JG, Zug KA, eds. Hypersensitivity syndrome and vasculitis. In: Skin disease: diagnosis and treatment. Philadelphia: Elsevier Mosby, 2005:284-7.
4. Wolff K, Johnson RA, Surmond D, eds. Erythema multiforme syndrome. In: Fitzpatrick's color atlas and synopsis of clinical dermatology. New York: McGraw Hill, 2005:140-7.
5. Philadelphia Department of Health. Vaccine adverse event reporting system. Available from http://vaers.hhs.gov/info.htm. Accessed September 19, 2005.
6. Callen JP. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. In: Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ, eds. Dermatologic signs of internal disease. Philadelphia: Saunders, 2003:55-9.
7. Leaute-Labreze C, Lamireau T, Chauki D, Maleville J, Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 2000;83:347-52.
8. Dogliotti M. Erythema multiforme: an unusual reaction to BCG vaccination. S A Med J 1980;57:532-3.
9. Frederiksen MS, Brenoe E, Trier J. Erythema multiforme minor following vaccination with paediatric vaccines. Scand J Infect Dis 2004;36:154-5.
10. Leung AKC, Szabo TF. Erythema multiforme following diphtheria-pertussis- tetanus vaccination. Kobe J Med Sci 1987;33:121-4.
11. Watson L. Meningococcal vaccination. Patient Care 2006;January:14-15.
12. U.S. Food and Drug Administration. FDA news. Available from http//:www.fda.gov. Accessed September 30, 2005.
13. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2005;54(RR07):1-21.
14. Wolverton SE, Callen JP. Cutaneous drug eruptions. In: Callen JP, Jorizzo JL, Bolognia JL, Piette WW, Zone JJ, eds. Dermatologic signs of internal disease, Philadelphia: Saunders, 2003:343-6.
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.